Feedback / Questions
AVT23 (omalizumab biosimilar) - Kashiv Biosci, Alvotech, Advanz Pharma, MS Pharma
https://www.businesswire.com/news/home/20250805355377/en/Kashiv-BioSciences-and-MS-Pharma-Enter-into-MENA-License-and-Supply-Agreement-for-ADL-018-Biosimilar-Candidate-to-XOLAIR-bOmalizumab
Aug 5, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next